Used in pharmaceutical research as a key intermediate for synthesizing targeted protein degraders, especially in the development of PROTACs (Proteolysis Targeting Chimeras). Its structure enables linkage between an E3 ligase binder and a target protein ligand, facilitating intracellular protein degradation. The alkyne group allows for bioorthogonal conjugation via click chemistry, making it valuable in labeling, pull-down assays, and probe development. Also employed in medicinal chemistry for optimizing pharmacokinetic properties and improving cellular permeability in drug discovery programs.